Skip to Main Content

Paper Details

Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.
Contemp Clin Trials
9
2021
AD, Alzheimer's, Alzheimer's Disease, Alzheimer's disease, Cholinesterase, Eligard, Leuprolide, Leuprolide acetate, Neurologic Decline, Neurologic Decline in, acetylcholinesterase, donepezil, endometriosis, gonadotropin, gonadotropin-, leuprolide acetate, prostate cancer, releasing hormone, women
Author NameAffiliation
Judith D GoldbergNew York University School of Medicine
Judith D GoldbergNew York University School of Medicine
James E GalvinComprehensive Center for Brain Health, University of Miami, Miller School of Medicine
Lidia GlodzikBrain Health Imaging Institute
Mony J de LeonBrain Health Imaging Institute
Tsivia HochmanNew York University School of Medicine
  • 1 - 6

Datasets

Release 1.2